Search for companies, drugs, and catalysts
Drugs in Pipeline
2
Phase 3 Programs
Upcoming Catalysts
0
Next Catalyst
None scheduled
bevacizumab
Age-related Macular Degeneration
ranibizumab
0 upcoming, 0 past
No catalysts found.
